|1||NCT03229278||Recruiting||Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma||
||Other / NIH||
||27||All||18 Years and older (Adult, Senior)||NCT03229278||051707
|August 17, 2017||July 30, 2019||July 30, 2019||July 25, 2017||November 17, 2017||
|2||NCT02465060||Recruiting||NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma||
||6452||All||18 Years and older (Adult, Senior)||NCT02465060||NCI-2015-00054
|August 12, 2015||June 30, 2022||June 30, 2022||June 8, 2015||February 20, 2018||
† Study has passed its completion date and status has not been verified in more than two years.